Questions remain after FDA slimly approves Merk COVID antiviral pill

Name: Questions remain after FDA slimly approves Merk COVID antiviral pill
Uploaded: 2021-12-01T17:31:18+00:00
Duration: 7 min 49 s
Description: Federal health regulators slimly approved Merk's COVID-19 antiviral pill on Tuesday but questions still remain about the drugs efficacy amid the discovery of the Omicron variant. Director of the Penn Institute for Immunology Dr. John Wherry joins Good Day Philadelphia to discuss.

Federal health regulators slimly approved Merk's COVID-19 antiviral pill on Tuesday but questions still remain about the drugs efficacy amid the discovery of the Omicron variant. Director of the Penn Institute for Immunology Dr. John Wherry joins Good Day Philadelphia to discuss.

Posted December 1, 2021 12:31pm EST